Our solutions support you in developing strategies to improve the overall portfolio risk/return profile. We can do this by leveraging proprietary data to quantify the likelihood of approval and probability of successful transition through the development phases for any compound.
Our experts work with you to understand your particular needs and deliver customized intelligence which you can use to inform your forecasting, licensing, business development and accounting decisions. We’ll do the heavy lifting of pharmaceutical data and analysis so you can make better decisions.
• Do I have the right assets (products, pipeline) to drive sustainable business growth? Profitability? Cash flow?
• What is the risk profile of my portfolio? (LOE, LCM, competitor launches, other external events?)
• Do I have the right balance between cash cows, future stars, and investment opportunities to balance risk and returns?
• What is the probability adjusted NPV of my pipeline?
• Which in-licensing opportunities would best fit into our portfolio?
• How much should I pay for a product acquisition?
• Am I investing in the right geographic markets?